hypothyroidism and glp 1 Glucagon-like peptide receptor agonist use risk of thyroid cancer: Scandinavian cohort study Do GLP-1 Agonists Cause Thyroid

Prescribing and dosing

46 Liraglutide is not currently subsidised by the PBS and therefore incurs additional out-of-pocket expenses for patients but is not limited by PBS restrictions on combination prescribing

An epidemiologic study by Apnimed, a clinical-stage pharmaceutical company developing AD109, an oral drug candidate for OSA, demonstrated that most people with OSA60.6%are not obese

Nichita, S.M

Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin